Published in Nanotechnol Sci Appl on September 07, 2012
A holistic approach to targeting disease with polymeric nanoparticles. Nat Rev Drug Discov (2015) 1.31
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials (2014) 0.94
Silver and gold nanoparticles exposure to in vitro cultured retina--studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activity. PLoS One (2014) 0.90
Nanoparticle formulation of ormeloxifene for pancreatic cancer. Biomaterials (2015) 0.88
Pulmonary surfactant augments cytotoxicity of silica nanoparticles: Studies on an in vitro air-blood barrier model. Beilstein J Nanotechnol (2015) 0.82
Inhalation of silver nanomaterials--seeing the risks. Int J Mol Sci (2014) 0.80
Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics. Drug Des Devel Ther (2015) 0.79
Cell type-specific response to high intracellular loading of polyacrylic acid-coated magnetic nanoparticles. Int J Nanomedicine (2015) 0.77
Changes in Physiological and Agronomical Parameters of Barley (Hordeum vulgare) Exposed to Cerium and Titanium Dioxide Nanoparticles. Int J Environ Res Public Health (2016) 0.77
Intracellular calcium levels as screening tool for nanoparticle toxicity. J Appl Toxicol (2015) 0.76
Increasing roughness of the human breast cancer cell membrane through incorporation of gold nanoparticles. Int J Nanomedicine (2016) 0.75
Toxicogenomics analysis of mouse lung responses following exposure to titanium dioxide nanomaterials reveal their disease potential at high doses. Mutagenesis (2016) 0.75
Therapeutic Potential of Natural Product-Based Oral Nanomedicines for Stroke Prevention. J Med Food (2016) 0.75
Nanocomplexes of an insulinotropic drug: optimization, microparticle formation, and antidiabetic activity in rats. Int J Nanomedicine (2014) 0.75
Hyperthermia using nanoparticles - Promises and pitfalls. Int J Hyperthermia (2016) 0.75
Increased cellular uptake of lauryl gallate loaded in superparamagnetic poly(methyl methacrylate) nanoparticles due to surface modification with folic acid. J Mater Sci Mater Med (2016) 0.75
Crosstalk of Nanosystems Induced Extracellular Vesicles as Promising Tools in Biomedical Applications. J Membr Biol (2017) 0.75
Absence of systemic toxicity in mouse model towards BaTiO3 nanoparticulate based eluate treatment. J Mater Sci Mater Med (2015) 0.75
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth. Breast Cancer Res Treat (2017) 0.75
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A (2006) 6.62
Dynamics and mechanics of the microtubule plus end. Nature (2003) 4.68
PLGA-based nanoparticles: an overview of biomedical applications. J Control Release (2012) 4.39
Cytoplasmic dynein-dependent vesicular transport from early to late endosomes. J Cell Biol (1993) 4.12
Actin-dependent propulsion of endosomes and lysosomes by recruitment of N-WASP. J Cell Biol (2000) 3.71
Coordinated protein sorting, targeting and distribution in polarized cells. Nat Rev Mol Cell Biol (2008) 3.63
Molecular motors. Nature (2003) 3.49
A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release (2008) 3.27
Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res (1996) 3.11
Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res (2007) 3.03
Powering membrane traffic in endocytosis and recycling. Nat Rev Mol Cell Biol (2006) 2.67
Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci (2009) 2.63
Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J Cell Sci (2002) 2.54
Microtubule motors at the intersection of trafficking and transport. Trends Cell Biol (2006) 2.44
The actin cytoskeleton: a key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol (2005) 2.09
Apical trafficking in epithelial cells: signals, clusters and motors. J Cell Sci (2009) 2.08
Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex. Mol Biol Cell (2004) 2.05
Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small (2011) 2.00
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev (2010) 1.88
Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med (2005) 1.87
Lysosome-endosome fusion and lysosome biogenesis. J Cell Sci (2000) 1.82
Endocytosis at the nanoscale. Chem Soc Rev (2012) 1.80
Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules (2011) 1.79
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm (2008) 1.78
Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov (2010) 1.73
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials (2005) 1.69
Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials (2007) 1.59
A dual role for Ca(2+) in autophagy regulation. Cell Calcium (2011) 1.56
Actin filaments and myosin I alpha cooperate with microtubules for the movement of lysosomes. Mol Biol Cell (2001) 1.56
Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano (2009) 1.54
Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol (2001) 1.49
Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc Chem Res (2011) 1.45
Intracellular transport by active diffusion. Trends Cell Biol (2009) 1.37
Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One (2011) 1.36
Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev (2011) 1.34
Lipoprotein-inspired nanoparticles for cancer theranostics. Acc Chem Res (2011) 1.30
Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials (2011) 1.26
Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst (2010) 1.25
Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. Biomacromolecules (2009) 1.24
Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicol Appl Pharmacol (2010) 1.20
Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology (2011) 1.20
Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live HeLa cells. ACS Nano (2010) 1.19
Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int J Nanomedicine (2010) 1.19
Subcellular compartment targeting of layered double hydroxide nanoparticles. J Control Release (2008) 1.15
Autophagy proteins in macroendocytic engulfment. Trends Cell Biol (2012) 1.15
E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow. Adv Mater (2011) 1.12
Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles. Arch Toxicol (2011) 1.12
Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J Biomed Mater Res A (2010) 1.10
Cholera toxin B conjugated quantum dots for live cell labeling. Nano Lett (2007) 1.08
Unmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neurons. Environ Health Perspect (2008) 1.08
Smart multifunctional nanostructure for targeted cancer chemotherapy and magnetic resonance imaging. ACS Nano (2011) 1.08
Characterization of the intracellular dynamics of a non-degradative pathway accessed by polymer nanoparticles. J Control Release (2007) 1.07
Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide. Biomaterials (2010) 1.06
Action potential changes associated with the inhibitory effects on voltage-gated sodium current of hippocampal CA1 neurons by silver nanoparticles. Toxicology (2009) 1.04
Magnetic micro- and nanoparticle mediated activation of mechanosensitive ion channels. Med Eng Phys (2005) 1.04
Mitochondria and PGC-1α in Aging and Age-Associated Diseases. J Aging Res (2011) 1.04
Intracellular O2 sensing probe based on cell-penetrating phosphorescent nanoparticles. ACS Nano (2011) 1.03
Mechanosensitive gating of CFTR. Nat Cell Biol (2010) 1.03
Influences of nanoparticle zinc oxide on acutely isolated rat hippocampal CA3 pyramidal neurons. Neurotoxicology (2008) 1.01
Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur J Pharm Biopharm (2007) 1.00
Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer. Mol Pharm (2012) 1.00
Intracellular organelle-targeted non-viral gene delivery systems. J Control Release (2011) 0.98
Contrasting macrophage activation by fine and ultrafine titanium dioxide particles is associated with different uptake mechanisms. Part Fibre Toxicol (2011) 0.98
Regulation of epithelial permeability by the actin cytoskeleton. Cytoskeleton (Hoboken) (2011) 0.98
Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnology (2011) 0.97
Toxic response of nickel nanoparticles in human lung epithelial A549 cells. Toxicol In Vitro (2011) 0.93
Zinc oxide nanoparticle disruption of store-operated calcium entry in a muscarinic receptor signaling pathway. Toxicol In Vitro (2010) 0.92
Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum. Adv Drug Deliv Rev (2007) 0.92
Redox-active polymer microcapsules for the delivery of a survivin-specific siRNA in prostate cancer cells. ACS Nano (2011) 0.92
Langendorff heart: a model system to study cardiovascular effects of engineered nanoparticles. ACS Nano (2011) 0.91
Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations. Mol Pharm (2012) 0.90
Gold revolution--gold nanoparticles for modern medicine and surgery. J Nanosci Nanotechnol (2011) 0.89
Peptides in DNA delivery: current insights and future directions. Drug Discov Today (2008) 0.88
Recent advances in basic and clinical nanomedicine. Med Clin North Am (2007) 0.88
Effect of carbon nanoparticles on renal epithelial cell structure, barrier function, and protein expression. Nanotoxicology (2010) 0.87
Design of a pH-sensitive polymeric carrier for drug release and its application in cancer therapy. Clin Cancer Res (2004) 0.87
Comparative in vitro cytotoxicity study of carbon nanotubes and titania nanostructures on human lung epithelial cells. J Hazard Mater (2011) 0.86
Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles. Nanomedicine (2011) 0.86
Cellular responses induced by cerium oxide nanoparticles: induction of intracellular calcium level and oxidative stress on culture cells. J Biochem (2011) 0.86
SLN, NLC, LDC: state of the art in drug and active delivery. Recent Pat Drug Deliv Formul (2011) 0.85
Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles. J Physiol Pharmacol (2011) 0.85
Polystyrene nanoparticles activate ion transport in human airway epithelial cells. Int J Nanomedicine (2011) 0.84
Luminescent nanoparticles and their use for in vitro and in vivo diagnostics. Expert Rev Mol Diagn (2012) 0.84
Local motion analysis reveals impact of the dynamic cytoskeleton on intracellular subdiffusion. Biophys J (2012) 0.84
In vitro study on influence of nano particles of CuO on CA1 pyramidal neurons of rat hippocampus potassium currents. Environ Toxicol (2009) 0.83
Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs. Int J Nanomedicine (2012) 0.83
Enhancement of odorant-induced responses in olfactory receptor neurons by zinc nanoparticles. Chem Senses (2009) 0.81
Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles. J Control Release (2012) 0.81
The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier. J Drug Deliv (2011) 0.79
A biophysical model of intracellular distribution and perinuclear accumulation of particulate matter. Biophys Chem (2011) 0.79
Cytosolic delivery of LDL nanoparticle cargo using photochemical internalization. Photochem Photobiol Sci (2011) 0.78
Functionalized nanosystems for targeted mitochondrial delivery. Mitochondrion (2011) 0.78
Single-molecule study on intermolecular interaction between C60 and porphyrin derivatives: toward understanding the strength of the multivalency. Langmuir (2009) 0.77
pH-responsive high-density lipoprotein-like nanoparticles to release paclitaxel at acidic pH in cancer chemotherapy. Int J Nanomedicine (2012) 0.77
Self-assembled polymeric nanoparticles based on oleic acid-grafted chitosan oligosaccharide: biocompatibility, protein adsorption and cellular uptake. J Mater Sci Mater Med (2012) 0.77
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res (2005) 3.75
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci U S A (2004) 2.88
Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation (2005) 2.10
Secondary structure of the human cardiac Na+ channel C terminus: evidence for a role of helical structures in modulation of channel inactivation. J Biol Chem (2001) 1.78
Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination. Circ Res (2004) 1.43
Assessment of dynamic mechanical properties of the respiratory system during high-frequency oscillatory ventilation*. Crit Care Med (2013) 1.40
Pro: most climbers develop subclinical pulmonary interstitial edema. High Alt Med Biol (2011) 1.38
Airway responses to methacholine and exercise at high altitude in healthy lowlanders. J Appl Physiol (1985) (2009) 1.38
Consensus definitions to promote an evidence-based approach to management of the pleural space. A collaborative proposal by ESTS, AATS, STS, and GTSC. Eur J Cardiothorac Surg (2011) 1.05
Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation. J Biol Chem (2003) 0.93
Cardiac sodium channel diseases. Clin Chem Lab Med (2003) 0.93
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol Aging (2004) 0.88
Compositional changes in lipid microdomains of air-blood barrier plasma membranes in pulmonary interstitial edema. J Appl Physiol (1985) (2003) 0.88
Composition, biophysical properties, and morphometry of plasma membranes in pulmonary interstitial edema. Am J Physiol Lung Cell Mol Physiol (2002) 0.85
Endothelial cells as early sensors of pulmonary interstitial edema. J Appl Physiol (1985) (2004) 0.85
Surfactant administration for neonatal respiratory distress does not improve lung interstitial fluid clearance: echographic and experimental evidence. J Perinat Med (2010) 0.84
Changes in the mechanical properties of the respiratory system during the development of interstitial lung edema. Respir Res (2008) 0.84
Biochemical and morphological changes in endothelial cells in response to hypoxic interstitial edema. Respir Res (2006) 0.82
Lung toxicity induced by intratracheal instillation of size-fractionated tire particles. Toxicol Lett (2009) 0.82
Hypoxia-induced modifications in plasma membranes and lipid microdomains in A549 cells and primary human alveolar cells. J Cell Biochem (2008) 0.81
Comparison of a visual analogue scale and Lake Louise symptom scores for acute mountain sickness. High Alt Med Biol (2010) 0.81
Accumulative difference image protocol for particle tracking in fluorescence microscopy tested in mouse lymphonodes. PLoS One (2010) 0.80
Respiratory mechanics and fluid dynamics after lung resection surgery. Thorac Surg Clin (2010) 0.79
In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes. Am J Physiol Heart Circ Physiol (2006) 0.79
A biophysical model of intracellular distribution and perinuclear accumulation of particulate matter. Biophys Chem (2011) 0.79
Computer simulation of wild-type and mutant human cardiac Na+ current. Med Biol Eng Comput (2006) 0.79
Determinants of performance in 1,500-m runners. Eur J Appl Physiol (2011) 0.77
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages. Int J Nanomedicine (2013) 0.77
Experimental model to evaluate the effect of hydrothorax and lobar resection on lung compliance. Eur J Cardiothorac Surg (2013) 0.77
Gene expression analysis in interstitial lung edema induced by saline infusion. Biochim Biophys Acta (2003) 0.77
Inter-individual differences in control of alveolar capillary blood volume in exercise and hypoxia. Respir Physiol Neurobiol (2013) 0.76
Pro: rebuttal. High Alt Med Biol (2011) 0.75
Remodelling of membrane rafts expression in lung cells as an early sign of mechanotransduction-signalling in pulmonary edema. J Lipids (2011) 0.75
mRNA expression profile of selected oxygen sensing genes in the lung during recovery from chronic hypoxia. Biol Res (2013) 0.75
Dynamic investigation of interaction of biocompatible iron oxide nanoparticles with epithelial cells for biomedical applications. J Biomed Nanotechnol (2013) 0.75
Tissue-specificty Of Mitochondrial Adaptations After 4 Weeks Of Normobaric Hypoxia In Rats: 2038 Board #190 June 2, 3: 30 PM - 5: 00 PM. Med Sci Sports Exerc (2016) 0.75